San Diego-based company with manufacturing facilities in Irvine, Calif. and Paris, France.

Sanofi Pasteur Ltd. develops, manufactures, and markets vaccines and immunotherapeutic products. It offers vaccines for haemophilus influenza type B (Hib), diphtheria, pertussis, poliomyelitis, tetanus, hepatitis A, influenza, poliomyelitis, rabies, meningococcal disease, typhoid fever, and yellow fever, as well as oncology products for bladder cancers. The company was founded John Gerald FitzGerald in 1914 and is headquartered in Toronto, Canada.

Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in four clinical trials for HPV-associated diseases: recurrent/refractory cervical cancer (India), locally advanced cervical cancer (GOG/NCI US study), head and neck cancer (CRUK study), and anal cancer (BrUOG). Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence.

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders and other rare diseases. It offers proprietary AAV technology, manufacturing capabilities, and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry. Its pipeline includes clinical-stage programs in Pompe disease and congestive heart failure and a diverse preclinical portfolio of therapeutics targeting neuromuscular, CNS, and other diseases, as well as out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The company’s gene therapy platform includes Pro10, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid, and promoter library. Asklepios BioPharmaceutical was founded in 2001 and is headquartered in Research Triangle Park, North Carolina.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Miles is a mobile app that automatically tracks and logs mileage for business purposes. Miles users can now create and export their mileage logs without the need of manual input.

Spirovant Sciences, Inc. is a gene therapy company, which engages in the development of gene therapies for cystic fibrosis and other lung diseases. It offers AAV platform which consists of a highly optimized transgene payload, a novel AAV capsid, and an augmenter; and lentiviral platform, a pseudotyped with an envelope protein which has demonstrated capability to transduce human airway epithelia from apical surfaces. Its pipeline include SPIRO-2101, SPIRO-2102, and SPIRO 2110. The company was founded by Joan Lau and Eric Yuen and is headquartered in Philadelphia, PA.

Jiangsu Feiya Chemical Industry Group Co., Ltd., established on 1995-03-15, Business scope includes hazardous chemicals:Diphenylamine(20000Ton/year),2-picoline(300Ton/year),ammonia(2000Ton/year),ammonia solution[Ammonia>10%](1500Ton/year)***Production,Sales;Other business(Do not store):Pure wholesale operation of explosive chemicals:nitric acid,sulfur;other hazardous chemicals:toluene,Mixture of xylene isomers,Isobutylene,2,4,4-Trimethyl-1-Pentene,2,4,4-Trimethyl-2-Pentene,Dicyclopentadiene(Dicyclopentadiene),phenol,2-cresol(o-cresol),3-cresol(m-cresol),4-cresol(p-cresol),cresol,petroleum ether,Methanol,Sodium methoxide,ethanol[Anhydrous],acetone,2-Phenylpropylene(ɑ-methyl styrene),Styrene[stable],alkyl,Aryl or Toluene Sulfonic Acid[Contains free sulfuric acid](p-Toluenesulfonic acid),Acetic acid[content>80%](acetic acid),Sodium fluorosilicate,Cyclohexane,Toluene diisocyanate,3-picoline,4-picoline,methanesulfonic acid,sodium sulfide,sulfuric acid,Fuming sulfuric acid,coal tar,Azodicarbonamide,Potassium hydroxide,potassium hydroxide solution[Content ≥30%],sodium hydroxide,sodium hydroxide solution,Solvent oil[Closed cup flash point ≤60ºC],Phosphorus trichloride,Phosphorus oxychloride,boron trifluoride,Boron trifluoride diethyl ether complex,2-tert-butylphenol,4-tert-butylphenol,Acetonitrile,Methyl acrylate[stable],n-octyl mercaptan,Dimethyl Sulfate,sulfur dioxide,Dimethyl carbonate,Dibutylamine,carbon disulfide,Copper chloride;(Business premises shall not store hazardous chemicals;Hazardous chemicals shall not be operated beyond the scope.***)Production of nonylated diphenylamine,Sales;Chemical product sales(Excluding hazardous chemicals);Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Environmental Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

MSD Italia Srl, part of Merck & Co., Inc., is an Italian company located in Rome. The firm manufactures pharmaceutical products. It was founded in 1891. Nicoletta Luppi is the current CEO, occupying that position since 2003.